Cite
APA Citation
Stinchcombe, T. E., Janne, P. A., Wang, X., Bertino, E. M., Weiss, J. M., Bazhenova, L., Gu, L., Lau, C. J., Paweletz, C. P., Jaslowski, A. J., Gerstner, G. J., Baggstrom, M. Q., Graziano, S. L., Bearden, J., & Vokes, E. E. (n.d.). 1444PA randomized phase II trial of erlotinib or erlotinib and bevacizumab in patients with advanced EGFR mutant non-small cell lung cancer (NSCLC). Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095518949.0x00002f